论文信息 - A phase II/III, double-blind, randomized trial comparing maintenance lapatinib versus placebo after first line chemotherapy in HER1/2 positive metastatic bladder cancer patients. - 字舞流文

A phase II/III, double-blind, randomized trial comparing maintenance lapatinib versus placebo after first line chemotherapy in HER1/2 positive metastatic bladder cancer patients.

D. Berney | R. Huddart | T. Powles | S. Sundar | Robert J. Jones | S. Crabb | J. Chester | T. Elliott | S. Jagdev | S. Chowdhury | M. Beresford | S. Hussain | A. Stockdale | S. Sarker | A. Macdonald | C. Ackerman | S. Hilman | J. Frew